Introduction:
The generic active pharmaceutical ingredient (API) market in Israel has been experiencing steady growth in recent years, driven by increasing demand for affordable medications and the country’s strong pharmaceutical manufacturing capabilities. According to industry reports, Israel is one of the top players in the global API market, with a market size of over $1 billion and a production volume of more than 20,000 tons annually.
Top 10 Generic Active Pharmaceutical Ingredient (API) Manufacturers in Israel:
1. Teva Pharmaceutical Industries:
– Market share: 30%
– Teva Pharmaceutical Industries is the largest generic API manufacturer in Israel, with a strong global presence and a wide range of products. The company’s high-quality APIs are used in a variety of medications and are known for their reliability and effectiveness.
2. Perrigo Company plc:
– Market share: 15%
– Perrigo Company plc is another major player in the Israeli API market, specializing in the production of generic APIs for various therapeutic categories. The company’s focus on innovation and quality has helped it maintain a significant market share in Israel and beyond.
3. Mylan N.V.:
– Market share: 12%
– Mylan N.V. is a leading generic API manufacturer in Israel, known for its diverse portfolio of APIs and its commitment to quality and affordability. The company’s strong R&D capabilities and global distribution network have helped it establish a strong presence in the market.
4. Neopharm Group:
– Market share: 8%
– Neopharm Group is a prominent Israeli API manufacturer, specializing in the production of high-quality APIs for various therapeutic areas. The company’s focus on innovation and customer satisfaction has helped it maintain a competitive edge in the market.
5. Neurim Pharmaceuticals:
– Market share: 6%
– Neurim Pharmaceuticals is a fast-growing API manufacturer in Israel, known for its focus on research and development and its commitment to producing innovative and effective APIs. The company’s strong pipeline of products and strategic partnerships have helped it gain market share in Israel and abroad.
6. H. Lundbeck A/S:
– Market share: 5%
– H. Lundbeck A/S is a leading API manufacturer in Israel, specializing in the production of APIs for the central nervous system and psychiatric disorders. The company’s high-quality APIs and commitment to research and development have helped it establish a strong presence in the market.
7. Taro Pharmaceutical Industries:
– Market share: 4%
– Taro Pharmaceutical Industries is a well-established API manufacturer in Israel, known for its focus on quality and innovation. The company’s diverse portfolio of APIs and strong manufacturing capabilities have helped it maintain a competitive position in the market.
8. RedHill Biopharma:
– Market share: 3%
– RedHill Biopharma is a growing API manufacturer in Israel, specializing in the production of APIs for gastrointestinal and inflammatory diseases. The company’s focus on research and development and its strong regulatory compliance have helped it gain market share in Israel and globally.
9. Kamada Ltd:
– Market share: 2%
– Kamada Ltd is a leading API manufacturer in Israel, known for its focus on developing and producing high-quality APIs for rare diseases and respiratory conditions. The company’s strong R&D capabilities and strategic partnerships have helped it establish a strong presence in the market.
10. Opko Health:
– Market share: 1%
– Opko Health is a prominent API manufacturer in Israel, specializing in the production of APIs for various therapeutic categories. The company’s focus on innovation and quality has helped it gain market share in Israel and internationally.
Insights:
The Israeli API market is expected to continue growing in the coming years, driven by increasing demand for generic medications and the country’s strong pharmaceutical manufacturing capabilities. According to industry forecasts, the market is projected to reach a value of over $1.5 billion by 2025, with a production volume of more than 25,000 tons annually. In order to maintain their competitive edge, Israeli API manufacturers will need to focus on innovation, quality, and compliance with global regulatory standards.
Related Analysis: View Previous Industry Report
